Common Stock, Shares, Outstanding of ArriVent BioPharma, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ArriVent BioPharma, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • ArriVent BioPharma, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 42,452,251, a 26% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

ArriVent BioPharma, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 42,452,251 +8,745,486 +26% 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q3 2025 40,852,312 +7,157,957 +21% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 37,490,439 +3,981,349 +12% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 34,040,996 +547,246 +1.6% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 33,706,765 +30,961,285 +1128% 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q3 2024 33,694,355 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 33,509,090 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 33,493,750 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 2,745,480 31 Dec 2023 10-K 03 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.